SLC16A2 and Graves disease: Subdividing the full study group into different thyroid diseases, the prevalence of samples highly positive for MCT8-aAb was similar in the groups of Graves’ disease (n = 11), Hashimoto’s thyroiditis (n = 12) and other thyroid patients (n = 15) (Figure 5B).